James Hippel

2018

In 2018, James Hippel earned a total compensation of $2.4M as Senior Vice President of Finance and CFO at Bio-Techne, a 10% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$483,485
Option Awards$1,110,007
Salary$476,100
Stock Awards$370,000
Other$9,295
Total$2,448,887

Hippel received $1.1M in option awards, accounting for 45% of the total pay in 2018.

Hippel also received $483.5K in non-equity incentive plan, $476.1K in salary, $370K in stock awards and $9.3K in other compensation.

Rankings

In 2018, James Hippel's compensation ranked 4,751st out of 14,244 executives tracked by ExecPay. In other words, Hippel earned more than 66.6% of executives.

ClassificationRankingPercentile
All
4,751
out of 14,244
67th
Division
Manufacturing
1,787
out of 5,765
69th
Major group
Chemicals And Allied Products
647
out of 2,128
70th
Industry group
Drugs
544
out of 1,817
70th
Industry
Biological Products, Except Diagnostic Substances
110
out of 339
68th
Source: SEC filing on September 9, 2019.

Hippel's colleagues

We found four more compensation records of executives who worked with James Hippel at Bio-Techne in 2018.

2018

Charles Kummeth

Bio-Techne

Chief Executive Officer

2018

David Eansor

Bio-Techne

Senior Vice President Biotechnology

2018

Brenda Furlow

Bio-Techne

General Counsel

2018

Kim Kelderman

Bio-Techne

President, Diagnostics and Genomics

News

You may also like